Ascendis Pharma AS (A71) — Net Asset Quality Index
Ascendis Pharma AS (A71) has a Net Asset Quality Index of 24.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €2.00 Billion minus total liabilities of €1.52 Billion yields net assets of €487.97 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Ascendis Pharma AS for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Ascendis Pharma AS Net Asset Quality Index Over Time (2016–2025)
This chart shows how Ascendis Pharma AS's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the index stands at 24.4%, representing net assets of €487.97 Million against total assets of €2.00 Billion EUR. For live market cap and overall valuation, see how much is Ascendis Pharma AS worth.
Annual Net Asset Quality Index for Ascendis Pharma AS (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Ascendis Pharma AS from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check strategic asset allocation of Ascendis Pharma AS to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -12.5% | €-162.82 Million | €1.30 Billion | €1.47 Billion | ▼ -3.5 pp |
| 2024 | -9.0% | €-105.71 Million | €1.18 Billion | €1.29 Billion | ▲ +8.7 pp |
| 2023 | -17.6% | €-145.70 Million | €825.59 Million | €971.28 Million | ▼ -41.8 pp |
| 2022 | 24.2% | €263.35 Million | €1.09 Billion | €826.39 Million | ▼ -57.3 pp |
| 2021 | 81.4% | €883.63 Million | €1.08 Billion | €201.29 Million | ▼ -4.2 pp |
| 2020 | 85.6% | €838.71 Million | €979.79 Million | €141.08 Million | ▼ -2.6 pp |
| 2019 | 88.2% | €597.11 Million | €676.73 Million | €79.62 Million | ▲ +0.4 pp |
| 2018 | 87.8% | €280.05 Million | €318.97 Million | €38.92 Million | ▼ -0.9 pp |
| 2017 | 88.7% | €187.21 Million | €210.98 Million | €23.77 Million | ▼ -4.2 pp |
| 2016 | 92.9% | €176.61 Million | €190.07 Million | €13.46 Million | — |